Vésale Bioscience receives €1.8M grant for AMR phage project
Belgian company Vésale Bioscience has received €1.8 million ($1.9 million) in grants from the European…
January 18, 2023 - 3 minutes
Belgium
Get the latest news of biotech in Belgium. Learn more about the latest regulations, collaboration deals, and technology advancements of Belgian biotech companies.
ExeVir Bio secures funding for COVID program
ExeVir Bio, a Belgian biotech company developing nanobody therapies for broad protection against infectious diseases,…
January 9, 2023 - 3 minutes
PDC*line Pharma presents first immunological results from trial with PDC*lung01
PDC*line Pharma, a clinical stage biotech company has announced the first immunological results of its…
December 8, 2022 - 3 minutes
Novadip bone healing trial yields positive results
Novadip Biosciences SA has announced positive data from its phase 1/2 clinical trial evaluating the…
December 8, 2022 - 5 minutes
Polyplus announces completion of acquisition of Xpress Biologics to expand plasmid DNA
Polyplus has announced the completion of an acquisition of Belgian Xpress Biologics to expand plasmid…
December 8, 2022 - 2 minutes
UCB publishes Lennox-Gastaut syndrome study data
UCB has announced the publication of long-term open-label extension (OLE) study results of FINTEPLA (fenfluramine)…
November 23, 2022 - 4 minutes
Sequana Medical has positive results for heart failure therapy drug
Sequana Medical has had some very positive top-line results from a phase 2a study, that…
November 15, 2022 - 3 minutes
BioSenic’s autoimmune disease platform adapting to meet unmet medical needs
BioSenic’s systemic autoimmune disease platform, originally designed by Medsenic, is now developing controlled dosages and…
November 14, 2022 - 4 minutes
Novadip Biosciences raises €40M for bone defect treatments
Novadip Biosciences has raised an additional €40 million ($39.2 million) in a series B equity…
November 4, 2022 - 5 minutes
Beyond Biotech podcast 20: BioWin, eTherapeutics, CMT Research Foundation
This week, we have three interviews, and four guests. We chatted with Keith Fargo, chief…
October 28, 2022 - 3 minutes
Domain Therapeutics to start clinical trials of solid tumor treatment
Domain Therapeutics says its immuno-oncology candidate has been cleared in Belgium and France, leading to…
October 19, 2022 - 2 minutes
Biocartis starts European commercialization of liver cancer test
Biocartis Group NV has started the commercialization in Europe of the HepatoPredict test as a…
October 10, 2022 - 3 minutes
